Table 3.
Incidence rates and hazard ratios of shoulder adhesive capsulitis according to T2DM status
| Groups | Total no. | No. of AC | Duration, yra | IRb | HR (95% CI) |
||
|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |||||
| Normal | 2,451,790 | 184,673 | 19,535,157.61 | 9.4534 | 1 (ref) | 1 (ref) | 1 (ref) |
| Prediabetes | 782,314 | 72,976 | 6,126,162.25 | 11.9122 | 1.261 (1.25–1.272) | 1.088 (1.079–1.098) | 1.084 (1.075–1.094) |
| New-T2DM | 99,748 | 11,348 | 759,910.63 | 14.9333 | 1.583 (1.553–1.613) | 1.313 (1.288–1.339) | 1.312 (1.287–1.337) |
| T2DM | 137,893 | 24,191 | 992,406.81 | 24.3761 | 2.592 (2.558–2.627) | 1.492 (1.472–1.513) | 1.473 (1.452–1.494) |
| P valuec | <0.0001 | <0.0001 | <0.0001 | ||||
Model 1: unadjusted; Model 2: adjusted for age and sex; Model 3: adjusted for age, sex, smoking status, alcohol consumption, regular exercise, hypertension, dyslipidemia, and body mass index.
T2DM, type 2 diabetes mellitus; AC, shoulder adhesive capsulitis; IR, incidence rate; HR, hazard ratio; CI, confidence interval.
a
Duration, total follow-up period of all subjects,
b
Per 1,000 person-years,
c
P value for trend, according to Cox proportional hazard regression analyses.